Spots Global Cancer Trial Database for Iscar for Supplemental Care in Stage IV Lung Cancer
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Iscar for Supplemental Care in Stage IV Lung Cancer
Official Title: Iscar for Supplemental Care in Stage IV Lung Cancer
Study ID: NCT00079794
Conditions
Study Description
Brief Summary: The purpose of this study it to determine whether supplemental treatment with Iscar improves immune function and quality of life among Stage IV non-small cell lung carcinoma patients receiving conventional chemotherapy. Iscar is an herbal medicine made from the total plant extract of mistletoe. this preparation is already in use in Europe and its use in the US is likely to increase as cancer patients continue to seek alternative therapies.
Detailed Description: See Brief Summary
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Thomas Jefferson University, Philadelphia, Pennsylvania, United States
Contact Details
Name: Steven Rosenzweig, MD
Affiliation: Jefferson Medical College of Thomas Jefferson University
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
